- Home
- ALLR vs TTNP Comparison
ALLR vs TTNP Comparison
Compare ALLR & TTNP Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ALLR
- TTNP
- Stock Information
- Founded
- ALLR 2004
- TTNP 1991
- Country
- ALLR United States
- TTNP United States
- Employees
- ALLR N/A
- TTNP N/A
- Industry
- ALLR Biotechnology: Pharmaceutical Preparations
- TTNP Biotechnology: Biological Products (No Diagnostic Substances)
- Sector
- ALLR Health Care
- TTNP Health Care
- Exchange
- ALLR Nasdaq
- TTNP Nasdaq
- Market Cap
- ALLR 4.0M
- TTNP 3.4M
- IPO Year
- ALLR N/A
- TTNP 1996
- Fundamental
- Price
- ALLR $1.07
- TTNP $3.79
- Analyst Decision
- ALLR
- TTNP
- Analyst Count
- ALLR 0
- TTNP 0
- Target Price
- ALLR N/A
- TTNP N/A
- AVG Volume (30 Days)
- ALLR 1.4M
- TTNP 10.7K
- Earning Date
- ALLR 05-13-2025
- TTNP 05-14-2025
- Dividend Yield
- ALLR N/A
- TTNP N/A
- EPS Growth
- ALLR N/A
- TTNP N/A
- EPS
- ALLR N/A
- TTNP N/A
- Revenue
- ALLR N/A
- TTNP N/A
- Revenue This Year
- ALLR N/A
- TTNP N/A
- Revenue Next Year
- ALLR N/A
- TTNP N/A
- P/E Ratio
- ALLR N/A
- TTNP N/A
- Revenue Growth
- ALLR N/A
- TTNP N/A
- 52 Week Low
- ALLR $0.61
- TTNP $3.03
- 52 Week High
- ALLR $103.80
- TTNP $14.80
- Technical
- Relative Strength Index (RSI)
- ALLR 60.94
- TTNP 52.33
- Support Level
- ALLR $0.66
- TTNP $3.53
- Resistance Level
- ALLR $1.06
- TTNP $3.76
- Average True Range (ATR)
- ALLR 0.11
- TTNP 0.18
- MACD
- ALLR 0.04
- TTNP -0.00
- Stochastic Oscillator
- ALLR 88.37
- TTNP 69.05
About ALLR Allarity Therapeutics Inc.
Allarity Therapeutics Inc is a clinical-stage, precision medicine company. The company is actively advancing a pipeline of in-licensed oncology therapeutics for patients with difficult-to-treat cancers. Its Drug Response Predictor (DRP) technology refines patient selection and improves clinical outcomes. Its pipeline product includes Dovitinib, Stenoparib, Ixempra, and other formulations.
About TTNP Titan Pharmaceuticals Inc.
Titan Pharmaceuticals Inc is a development stage company developing proprietary therapeutics with utilizing ProNeura long-term, continuous drug delivery technology. The ProNeura technology has the potential to be used in developing products for treating a number of chronic conditions, where maintaining consistent, around-the-clock blood levels of medication may benefit the patient and improve medical outcomes.